Browsing Tag
Exblifep
1 post
Orchid Pharma (NSE: ORCHPHARMA) signs $178m Russia deal to commercialise Exblifep
Orchid Pharma signs a $178 million Russia deal for Exblifep. Read how the Pharmasyntez pact could reshape ORCHPHARMA’s global antibiotic strategy.